Form 4: Immunovant COO Sells Shares

Immunovant, Inc. reports that Chief Operating Officer Melanie Gloria sold a total of 17,714 shares of common stock on June 26, 2026.

Summary

• Melanie Gloria, Chief Operating Officer of Immunovant, Inc., sold a total of 17,714 shares of common stock on June 26, 2026.
• The sales were executed in multiple transactions at weighted average prices.
• The first transaction involved 14,748 shares sold at a weighted average price of $38.18, with individual prices ranging from $37.77 to $38.56.
• The second transaction involved 2,966 shares sold at a weighted average price of $38.95, with individual prices ranging from $38.78 to $39.13.
• Following these transactions, Gloria beneficially owns 224,393 shares of common stock.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as slightly negative due to the significant sale of shares by a key executive, although the exact reasons for the sale are not disclosed.

Negatives

• The Chief Operating Officer sold a significant number of shares (17,714).

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that insider selling, while not always negative, can sometimes signal a lack of confidence in future stock performance or a need for personal liquidity. Investors will monitor future transactions for patterns.

Stakeholder Impact

• Shareholders may view the COO's sale of shares with caution, potentially impacting investor sentiment.

Key Dates

Recommendation

The filing reports insider selling by the COO, which warrants attention. However, without further context on the reasons for the sale or broader company performance, a 'hold' recommendation is prudent, suggesting investors monitor the situation.

Keywords

Immunovant, IMVT, Form 4, insider trading, stock sale, Melanie Gloria, Chief Operating Officer